The proportions of patients responding to dmLT with IL-17A responses and IgA LTB were comparable (about 50%), whereas ALS IgA responses to CS6 and CS5 were more frequent than T cell responses to the same antigens (80-90% compared to 40-50%). The gene discussed is IL17A; the disease is amyotrophic lateral sclerosis.